ARS Pharmaceuticals (SPRY) Receivables - Other (2021 - 2025)
ARS Pharmaceuticals (SPRY) reported Receivables - Other of $4.3 million for Q3 2025, up 3109.77% on a YoY basis from $133000.0 in Q3 2024, and up 110.61% sequentially from $2.0 million in Q2 2025.
ARS Pharmaceuticals (SPRY) Receivables - Other (2021 - 2025) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 5 years of Receivables - Other data on file, last reported at $4.3 million in Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other rose 3109.77% year-over-year to $4.3 million; the trailing twelve-month figure through Sep 2025 stood at $4.3 million (up 3109.77% YoY), and the FY2024 full-year result was $1.2 million, up 88.96% from the prior year.
- Receivables - Other advanced to $4.3 million in Q3 2025, from $2.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $4.3 million in Q3 2025 to a low of $122000.0 in Q2 2024.
- A 5-year average of $839538.5 and a median of $307000.0 in 2023 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other slumped 65.04% in 2024 and soared 3109.77% in 2025, its largest moves.
- Tracing SPRY's Receivables - Other over 5 years: stood at $159000.0 in 2021, then soared by 33.96% to $213000.0 in 2022, then jumped by 206.1% to $652000.0 in 2023, then soared by 88.96% to $1.2 million in 2024, then soared by 246.51% to $4.3 million in 2025.
- Business Quant data shows SPRY's Receivables - Other at $4.3 million in Q3 2025, $2.0 million in Q2 2025, and $963000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.27 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 963,000.00 |
| Mar 31, 2025 | 963,000.00 |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 133,000.00 |
| Sep 30, 2024 | 133,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Sep 30, 2023 | 208,000.00 |
| Sep 30, 2023 | 208,000.00 |
| Jun 30, 2023 | 349,000.00 |
| Jun 30, 2023 | 349,000.00 |